Giant Hepatic Angiomyolipoma Mimicking
Hepatocellular Carcinoma

Güngör, Gökhan; Kayaçeti̇n, Ertuğrul; Bıyık, Murat; Özbek, Orhan; Uçar, Ramazan; Baba, Füsun; Demır, Ali

doi:10.15197/sabad.1.11.34

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The enhancement was weakened during the portal venous phase and delayed phase but still heterogeneous in nature adding more ambiguity to this dilemma. Most of case reports of HAML published in literature was demonstrated in Table 2 with all their demographic criteria [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19].…”

Section: Resultsmentioning

confidence: 99%

Utility of Immunohistochemistry in the Diagnosis of a Case of Hepatic Angiomyolipoma from a Tertiary Referral Centre for Liver Diseases

NA¹,

MM²

2016

J Hepatol Gastroint Dis

View full text Add to dashboard Cite

A single case of hepatic Angiomyolipoma (AML) over 25 years in a tertiary referral center for liver diseases is being presented. A 56-year old gentleman presented with abdominal pain, fullness and weight loss. A large left lobe mass in a background of non-cirrhotic liver was radiologically inscribed. The risk of rupture of together with the possibility of malignancy seedlings were the restraints against CT guided liver biopsy. Left lateral segmentectomy was the consulting surgical team's decisive maneuver. Gross pathological examination, histological evaluation and immunohistochemical analysis were performed to determine the nature of tumor. Results revealed normal serum levels of alpha-fetoprotein, CA 19.9 and carcinoembryonic antigen. Grossly the tumor exhibited variable consistency. Histologically, the tumor displayed three main constituents intermingled together; blood vessels, myoid cells and fat. Immunohistochemistry revealed positive immune reaction for CD34, alpha smooth muscle actin and S-100 in tumor tissue but negative for anti-human hepatocyte antibody.

show abstract